Log In
Print
BCIQ
Print
Print this Print this
 

ADXS-HPV (ADXS11-001) (formerly Lovaxin C)

  Manage Alerts
Collapse Summary General Information
Company Advaxis Inc.
DescriptionLive Listeria monocytogenes-based immunotherapy expressing HPV type 16 E7
Molecular Target Not applicable
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today